FDA Inspection 1214976 — Prime Lab LLC

Prime Lab LLC — FEI 3017199840

The FDA completed an inspection of Prime Lab LLC on Aug 4, 2023 in Ponce, PR. The inspection was classified OAI (Official Action Indicated — regulatory and/or administrative actions are recommended). 7 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Official Action Indicated (OAI)
End Date
Aug 4, 2023
Fiscal Year
2023
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Ponce, PR (United States)

Citations

IDCFRDescription
119421 CFR 211.42(c)Defined areas of adequate size for operations
121321 CFR 211.67(a)Cleaning / Sanitizing / Maintenance
136121 CFR 211.100(a)Absence of Written Procedures
176721 CFR 211.137(a)Expiration date lacking
184221 CFR 211.84(d)(1)Component identity verification
188321 CFR 211.165(a)Testing and release for distribution
900121 CFR 211.22(a)Lack of quality control unit

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.